Skip to search formSkip to main contentSkip to account menu

stage I melanoma

Known as: Stage I Skin Melanoma AJCC v6, stage I cutaneous melanoma, Stage I Melanoma of the Skin AJCC v6 
Stage I includes: IA (T1a, N0, M0); IB (T1b, N0, M0); (T2a, N0, M0). T1a: Melanoma is less than or equal to 1.0mm in thickness with or without… 
National Institutes of Health

Related topics

Related topics

9 relations
Body tissueIntegumentary systemMelanoma CellNeoplastic Cell

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2003
2003
Urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 and type 2 in stage I malignant melanoma.
The urokinase-type plasminogen activator (uPA) and its inhibitors type 1 (PAI-1) and type 2 (PAI-2) are considered to have a key… 
Review
1992
Review
1992
Influence of gender on survival in patients with stage I malignant melanoma.
1990
1990
Single cell DNA cytophotometry in clinical stage I malignant melanoma. Relationship to prognosis.
Histological sections of 50 clinical stage I cutaneous melanomas were analyzed by single cell DNA cytophotometry. Forty-two… 
Review
1989
Review
1989
Tumor thickness and prognosis in clinical stage I malignant melanoma
The current grouping of patients with malignant melanoma into thin, intermediate, and thick melanomas provides a convenient but… 
1989
1989
Late recurrence of stage I malignant melanoma
Although the introduction of well‐established risk factors has made the clinical course and prognosis of malignant melanoma… 
1989
1989
The influence of resection margin on prognosis in clinical stage I malignant melanoma of the lower leg.
The incidence of local recurrence and cumulative survival rate were compared for two groups of patients with stage I malignant… 
1987
1987
Changes in survival with clinical stage I malignant melanoma
Inclusion of patients referred to our cancer center following recurrence, by retracing the history and characteristics of these… 
1986
1986
The adjuvant prognostic value of nuclear morphometry in stage I malignant melanoma of the skin. A multivariate analysis.
: In order to evaluate the adjuvant prognostic value to tumor thickness of other clinical, qualitative histologic and… 
1985
1985
Efficacy of elective lymph node dissection in 2,347 patients with clinical stage I malignant melanoma.
The results of a largely prospective but non-randomized study of 2,347 patients with clinical Stage I malignant melanoma have… 
Highly Cited
1982
Highly Cited
1982
Prognostic Factors for Patients with Clinical Stage I Melanoma of Intermediate Thickness (1.51–3.99 mm)* A Conceptual Model for Tumor Growth and Metastasis
Fourteen variables were tested for their ability to predict visceral or bony metastases in 177 patients with clinical Stage I… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)